MARK ASSET MANAGEMENT LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 188 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARK ASSET MANAGEMENT LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$1,972,000
+85.5%
59,630
+82.8%
0.57%
+104.3%
Q1 2015$1,063,000
-76.9%
32,628
-77.5%
0.28%
-77.2%
Q4 2014$4,596,000
+85.5%
144,754
+44.6%
1.23%
+82.5%
Q3 2014$2,478,000
-38.7%
100,099
-44.1%
0.68%
+24.3%
Q2 2014$4,042,000
+356.7%
178,954
+392.3%
0.54%
+100.0%
Q1 2014$885,00036,3510.27%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders